Alpha-1 antitrypsin deficiency Clinical Trials
Conditions / Alpha-1 antitrypsin deficiency
Delta Trials records 1 clinical trial for Alpha-1 antitrypsin deficiency in its publicly accessible dataset. From the full dataset, 0 actively seeking eligible participants and 0 trials have reached completion. This research is conducted across 9 study locations around the world. An additional 1 trial are active but not currently open for enrollment. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
1
Total Trials
0
Recruiting
0
Completed
1
Other Active
0
Terminated since 2020
9
Study Locations
Browse by location (9 total)
- Hamilton, New Zealand 1 trialAll trials in Hamilton, New Zealand
- Fitzroy, Australia 1 trialAll trials in Fitzroy, Australia
- Halifax, Canada 1 trialAll trials in Halifax, Canada
- Birmingham, United Kingdom 1 trialAll trials in Birmingham, United Kingdom
- London, United Kingdom 1 trialAll trials in London, United Kingdom
- Aachen, Germany 1 trialAll trials in Aachen, Germany
- Toronto, Canada 1 trialAll trials in Toronto, Canada
- Turku, Finland 1 trialAll trials in Turku, Finland
- Cambridge, United Kingdom 1 trialAll trials in Cambridge, United Kingdom